Boron Neutron Capture Therapy Using CICS-1 and SPM-011 for Malignant Melanoma and Angiosarcoma

Conditions:   Malignant Melanoma;   Angiosarcoma Intervention:   Other: CICS-1 (investigational device),SPM-011(investigational drug) Sponsors:   Cancer Intelligence Care Systems, Inc.;   Stella Pharma Corporation Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials